An adverse event identification strategy based on physician self-referral uncovers as many adverse events as does a record review and is less costly. In addition, physician-identified events are more likely to be preventable and, thus, are targets for quality improvement.
Study Objective: To evaluate the potential ability of computerized information systems (KS) to identify and prevent adverse events in medical patients.Design: Clinical descriptions of all 133 adverse events identified through chart review for a cohort of 3,138 medical patients were evaluated by two reviewers.
Measurements:For each adverse event, three hierarchical levels of IS sophistication were considered: Level l-demographics, results for all diagnostic tests, and current medications would be available on-line; Level 2-all orders would be entered on-line by physicians; and Level 3-additional clinical data, such as automated problem lists, would be available on-line. Potential for event identificationand potential for event prevention were scored by each reviewer according to two distinct sets of event monitors.Results: Of all the adverse events, 53% were judged identifiable using Level 1 information, 58% were judged identifiable using Level 2 information, and 89% were judged identifiable using Level 3 information.The highest-yield event monitors for identifying adverse events were "panic" laboratory results, unexpected transfer to an intensive care unit, and hospital-incurred trauma. With information from Levels 1, 2, and 3, 5%, 13%, and 23% of the adverse events, respectively, were judged preventable. For preventing these adverse events, guided-dose algorithms, drug-laboratory checks, and drug-patient characteristic checks held the most potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.